wait for loaaing

"Cancer has been a leading cause of death, accounting for nearly one in six deaths worldwide each year.

In the early 20th century, the concept of "oncolytic bacteria" was initially formed.

We changed EcN' s Tsr chemoreceptor protein into Helicobacter pylori' s Tlpc Protein which can responds to lactic acid,so that EcN has the ability to target lactic acid.

To achieve a better treatment, we put a sword on this brave trooper, which is an antibody-coupling drug. ADC drugs have two parts: antibody and cytotoxic drugs. Like a missile divided into a guidance and a warhead.

In the future, we hoped that oncolytic therapy and synthetic biology can be better developed, bringing new possibilities for the treatment of tumors.

Learn More